absenc
standard
diagnosi
presenc
uniqu
clinic
syndrom
surpris
consider
differ
exist
number
report
incid
diseas
outcom
variou
infect
cardiothorac
transplant
cttx
recipi
public
date
employ
variabl
heterogen
definit
cttxrelat
infect
therebi
limit
comparison
type
incid
infect
generaliz
data
across
transplant
center
current
standard
intern
definit
infect
uniqu
relat
cttx
except
chaga
diseas
toxoplasmosi
purpos
present
work
formul
provid
consensusderiv
expert
opinion
definit
infect
cttx
epidemiolog
research
registri
data
use
standard
definit
infect
specif
relat
cttx
allow
meaning
comparison
type
incid
infect
differ
type
cttx
differ
regimen
immunosuppress
differ
transplant
center
therebi
improv
report
infectionrel
morbid
mortal
cardiothorac
transplant
definit
propos
herein
suitabl
epidemiolog
investig
intend
facilit
clinic
decisionmak
definit
describ
follow
review
approv
multidisciplinari
work
group
intern
societi
heart
lung
transplant
ishlt
definit
adapt
surveil
definit
healthcareassoci
sinus
tracheobronch
pneumonia
use
report
nation
healthcar
safeti
network
nhsn
center
diseas
control
prevent
cdc
surveil
system
patient
healthcar
personnel
safeti
definit
invas
fungal
infect
ifi
base
propos
european
organ
research
treatment
cancer
mycos
studi
group
nation
institut
health
eortcmsg
wherea
definit
american
societi
transplant
sourc
document
repres
foundat
defin
viral
infect
bacteri
infect
overview
bacteri
infect
major
contributor
complic
earli
posttranspl
period
heartand
lungtranspl
patient
bacteri
infect
eg
pretranspl
colon
donorderiv
infect
uniqu
issu
implic
cttx
recipi
therefor
definit
infect
epidemiolog
research
ishlt
registri
purpos
specif
address
herein
mani
bacteri
infect
eg
methicillinresist
staphylococcu
aureu
vancomysinresist
enterococcu
present
similarli
across
hospit
patient
solidorgan
transplant
sot
recipi
therefor
directli
address
follow
exist
literatur
cttx
larg
classifi
bacteri
infect
earli
eg
postop
late
onset
transplant
allow
transplant
clinician
determin
sourc
infect
focu
prevent
strategi
earli
empir
antibiot
treatment
regimen
tempor
onset
infect
timelin
use
classifi
infect
diagnos
hospit
set
nosocomi
onset
hour
patient
admit
hospit
communityacquir
infect
onset
time
admiss
within
hour
admiss
latter
definit
infect
may
artifici
set
cttx
infect
although
relat
healthcar
immunosuppress
may
occur
within
establish
timelin
nosocomi
infect
fulli
appreci
impact
potenti
sourc
infect
propos
use
categori
nosocomi
hour
hospit
communityacquir
prior
hour
hospit
ad
categori
communityacquir
transplantrel
infect
categori
would
includ
infect
pathogen
acquir
cttx
patient
prior
time
transplant
clearli
relat
immunocompromis
state
cttx
patient
transplant
may
increas
risk
specif
bacteri
pathogen
common
commun
pathogen
may
relat
donor
recipi
via
pretranspl
colon
respiratori
gastrointestin
gi
tract
therefor
regard
transplantrel
set
also
note
communityacquir
pneumonia
may
transplantrel
caus
organ
typic
associ
transplant
eg
fungal
multidrugresist
atyp
bacteria
respiratori
bacteri
infect
occur
frequent
lung
transplant
recipi
one
studi
episod
per
lung
transplant
per
year
report
definit
bacteri
pneumonia
present
signific
challeng
cttx
frequent
use
empir
antibacteri
agent
prior
specimen
collect
possibl
concurr
allograft
reject
make
use
standard
guidelin
present
center
diseas
control
prevent
cdc
healthcareassoci
infect
hcai
difficult
appli
addit
microbiolog
diagnost
procedur
may
routin
practic
mani
transplant
center
may
limit
employ
diagnost
criteria
infect
requir
quantif
bacteri
colonyform
unit
per
millilit
bronchoalveolar
lavag
bal
sampl
methodolog
valid
immunocompromis
host
standard
across
institut
threshold
propos
may
underestim
episod
bacteri
pneumonia
cttx
popul
earli
empir
intervent
antimicrobi
agent
prior
obtain
sampl
suspect
pneumonia
common
practic
presenc
endobronchi
stent
lung
transplant
recipi
complic
pictur
defin
variou
clinic
syndrom
reason
specif
classif
bacteri
pneumonia
cttx
recipi
propos
base
radiograph
find
clinic
symptom
microbiolog
histopatholog
includ
consider
acut
reject
lung
transplant
patient
lung
transplant
recipi
use
differenti
cytolog
bal
may
help
predomin
neutrophil
intracellular
bacteria
hematoxylineosin
gram
stain
suggest
presenc
bacteri
pneumonia
high
proport
lymphocyt
eosinophil
bal
hand
lymphocyt
eosinophil
bal
could
indic
acut
graft
reaction
although
cytomegaloviru
cmv
virus
atyp
pathogen
would
need
rule
acut
reject
ar
graft
lung
transplant
recipi
present
signific
consider
diagnosi
pneumonia
includ
due
bacteria
frequent
clinic
scenario
distinct
reject
infect
critic
depend
upon
histopatholog
find
mani
case
evid
infect
reject
coexist
therefor
set
lung
transplant
diagnosi
bacteri
pneumonia
precis
defin
confirm
exclus
ar
microbiolog
criteria
met
determin
ar
requir
histolog
examin
ar
document
clinic
laboratori
criteria
bacteri
pneumonia
also
fulfil
diagnosi
ar
concomit
pneumonia
possibl
accordingli
pneumonia
indic
pneumonia
combin
ar
direct
examin
light
microscopi
gram
stain
modifi
acidfast
bacilli
afb
stain
nocardia
spp
afb
stain
mycobacteria
cultur
includ
rapid
cultur
method
legionella
spp
mycobacteria
spp
prolong
cultur
period
detect
bacteriacaus
infect
endocard
bal
cell
analysi
ruleout
contamin
epitheli
cell
definit
bacteri
pneumonia
colon
cttx
given
tabl
wherea
definit
tracheobronch
given
tabl
ventilatorassoci
pneumonia
design
report
data
distinct
made
noninvas
invas
ventil
aspir
pneumonia
consid
criteria
fulfil
pneumonia
tabl
caus
type
pneumonia
note
multipl
concurr
episod
posttranspl
pneumonia
may
occur
determin
new
episod
singl
patient
resolut
initi
infect
must
determin
clinic
laboratori
histolog
evid
isol
new
pathogen
alon
indic
new
episod
pneumonia
contrast
second
pneumonia
may
develop
patient
singl
lung
transplant
contralater
lung
may
develop
independ
pneumonia
anoth
organ
sputum
sampl
frequent
contamin
airway
colon
eg
coagulaseneg
staphylococcu
enterococcu
spp
therefor
must
interpret
cautious
interferongamma
releas
assay
igra
serum
test
recommend
diagnosi
acut
tracheobronch
diseas
although
posit
result
indic
latent
diseas
recent
infect
use
screen
test
baselin
igra
test
perform
prior
transplant
episod
airway
colon
record
infect
histolog
represent
chronic
graft
reject
may
impact
diagnosi
bacteri
pneumonia
therefor
includ
criteria
pneumonia
definit
definit
possibl
pneumonia
categori
allow
record
pneumonia
lung
transplant
even
requir
diagnost
procedur
miss
may
occur
prior
antimicrobi
treatment
delay
diagnost
test
etc
lung
transplant
recipi
desir
alway
give
addit
inform
evid
acut
graft
reject
exist
either
clinic
histopatholog
diagnosi
possibl
concurr
infectionspneumonia
sinus
anastomot
tracheobronch
quantif
organ
bal
consid
essenti
diagnosi
ventilatorassoci
pneumonia
vap
howev
invas
diagnost
may
help
withdraw
antibacteri
therapi
may
prevent
emerg
multiresist
organ
futur
categori
bacteri
tracheobronch
classifi
probabl
proven
categori
diagnos
presenc
bronchoscop
find
refrain
use
term
microbiog
neg
tracheobroch
requir
evid
endobronchi
stentassoci
tracheobronch
bronchial
anastomot
infect
fungal
bacteri
categor
probabl
tabl
attempt
made
redefin
atyp
mycobacteri
infect
pulmonari
tracheobronch
lung
transplant
recipi
use
exist
definit
european
north
american
societi
encourag
data
emerg
prefer
document
use
antibiot
patient
pneumonia
time
cultur
data
collect
cardiothorac
transplant
recipi
increas
risk
viral
infect
sever
clinic
sequela
viral
infect
uniqu
consider
implic
cttx
recipi
definit
viral
infect
specif
address
herein
may
use
epidemiolog
research
registri
purpos
cttx
recipi
mani
nonrespiratori
viral
infect
present
similarli
across
sot
recipi
diagnosi
manag
viral
infect
address
ade
quat
guidelin
therefor
address
herein
respiratori
viral
infect
includ
newli
emerg
virus
occur
frequent
lung
transplant
recipi
epidemiolog
studi
suggest
associ
respiratori
viral
infect
develop
bronchiol
obliteran
syndrom
bo
studi
yield
mix
result
associ
respiratori
viru
infect
bo
remain
unclear
recent
avail
molecular
diagnost
includ
pcr
multiplex
gene
techniqu
recoveri
mani
virus
simultan
singl
specimen
increas
recoveri
pathogen
respiratori
infect
previous
consid
undetermin
etiolog
virus
identifi
uncer
definit
cmv
infect
diseas
especi
use
research
report
literatur
use
studi
methodolog
cmv
recoveri
shift
mani
center
past
decad
convent
viral
cultur
method
antigenemia
toward
quantit
molecular
diagnost
includ
pcr
hybrid
captur
assay
howev
issu
relat
recoveri
cmv
bal
fluid
absenc
histopatholog
evid
cmv
remain
unresolv
investig
ongo
resolv
issu
asymptomat
viral
shed
upper
oropharynx
cmv
distinguish
activ
cmv
diseas
definit
assist
assess
role
cmv
cttx
earli
studi
recoveri
cmv
viral
cultur
absenc
tissu
diagnosi
consid
diagnost
cmv
pneumon
howev
studi
suggest
cmv
recoveri
bal
predict
subsequ
cmv
pneumon
advent
sophist
molecular
diagnost
recoveri
cmv
bal
becam
specif
reproduc
compar
convent
shellvial
cultur
addit
studi
suggest
cmv
viral
load
bal
fluid
may
correl
invas
cmv
pneumonia
howev
util
cmv
viral
load
bal
predict
cmv
pneumon
remain
uncertain
studi
date
molecular
diagnost
whole
blood
plasma
bal
tissu
quantit
dna
pcr
hybrid
captur
assay
qualit
pcr
genotyp
resist
test
antigen
viral
cultur
convent
shellvial
centrifug
situ
immunohistochemistri
serolog
recommend
diagnosi
definit
respiratori
viral
infect
given
tabl
cttx
recipi
gener
lung
transplant
recipi
particular
highest
risk
mold
infect
recent
publish
data
suggest
cumul
incid
rate
year
among
mold
infect
overwhelm
major
infect
due
aspergillu
spp
follow
scedopsorium
spp
zygomycet
despit
advanc
antifung
therapi
mortal
remain
approxim
aspergillu
infect
candida
speci
note
major
pathogen
earli
cttx
period
although
rare
seen
lung
transplant
recipi
current
era
although
incid
invas
candidiasi
remain
low
lung
transplant
recipi
common
fungal
infect
note
heart
transplant
recipi
fungal
infect
lung
transplant
recipi
certain
characterist
make
uniqu
compar
sot
recipi
well
immunocompromis
host
includ
presenc
certain
risk
factor
airway
ischemia
nativ
lung
uniqu
clinic
syndrom
includ
tracheobronch
bronchial
anastomot
infect
colonizationsyndrom
observ
lung
transplant
recipi
figur
reject
syndrom
lung
transplant
recipi
complic
clinic
present
diagnosi
fungal
infect
base
histolog
alon
may
accur
due
concomit
presenc
acut
chronic
reject
individu
similarli
uniqu
clinic
syndrom
fungal
infect
set
apart
immunocompromis
host
diagnost
util
noninvas
test
also
differ
serum
galactomannan
markedli
lower
sensit
lung
transplant
recipi
compar
immunocompromis
host
similarli
sensit
serolog
marker
serum
cryptococc
coccidiod
antigen
histoplasma
urin
antigen
may
variabl
use
bal
gm
result
sensit
optic
densiti
od
index
use
cutoff
higher
cutoff
od
yield
better
result
one
studi
suggest
use
bal
gm
diagnosi
invas
aspergillosi
ia
lung
transplant
recipi
similarli
fungal
pcr
especi
bal
specimen
like
less
sensit
diagnosi
diseas
bal
specimen
immunocompromis
host
owe
colon
airway
cell
wall
compon
fungi
also
use
diagnosi
fungal
infect
current
avail
nonspecif
neg
case
cryptococcosi
zygomycosi
recent
studi
lung
transplant
recipi
serum
sensit
report
wherea
specif
mere
mycos
studi
group
msg
european
organ
research
treatment
eortc
recent
updat
definit
fungal
infect
immunocompromis
host
definit
repres
excel
attempt
standard
report
fungal
infect
studi
howev
fail
address
uniqu
natur
clinic
syndrom
lung
transplant
recipi
particularli
colon
tracheobronch
bronchial
anastomot
infect
also
radiolog
present
invas
mycos
cardiothorac
organ
transplant
recipi
may
conform
classic
halo
sign
present
neutropen
stem
absenc
biopsi
categor
probabl
presenc
histolog
find
acut
reject
fungal
invas
classifi
acut
reject
proven
fungal
infect
b
presenc
mosaic
appear
groundglass
opac
may
repres
develop
bronchiol
obliteran
syndrom
oblit
bronchiol
c
isol
nonpathogen
mold
cultur
eg
cladosporium
spp
phialemonium
chaetomium
cunninghamella
syncephalastrum
curvularia
dactylaria
graphium
phialophora
nonpathogen
fungi
eg
penicillium
nonmarnefii
paecilomyc
basidiomyct
qualifi
probabl
categori
consid
proven
categori
cell
transplant
recipi
figur
moreov
definit
account
differ
sensit
serolog
test
particularli
galactomannan
lung
transplant
recipi
addit
categori
possibl
fungal
infect
might
applic
lung
transplant
recipi
owe
multitud
possibl
diagnos
patient
american
societi
transplant
ast
also
put
forward
set
definit
use
studi
infect
sot
recipi
ast
definit
take
account
uniqu
clinic
syndrom
lung
transplant
recipi
lack
detail
descript
clinic
syndrom
report
studi
fungal
infect
lung
transplant
recipi
use
divers
definit
follow
set
definit
propos
standard
report
fungal
infect
particularli
mold
yeast
endem
mycos
candida
spp
cryptococcu
spp
infect
cttx
recipi
especi
among
gener
lung
transplant
recipi
isol
nonpathogen
mold
nonpathogen
fungi
bal
sputum
believ
satisfi
microbiolog
criteria
diagnosi
probabl
invas
fungal
infect
patient
without
histolog
confirm
tabl
howev
definit
fungal
infect
address
pneumocysti
jiroveci
infect
previous
adequ
defin
use
cttx
direct
examin
light
microscopi
gram
giemsa
calcofluor
stain
cultur
histopatholog
routin
stain
hemotoxylineosin
special
gomori
methenamin
silver
mucicarmin
period
acidschiff
direct
immunofluoresc
situ
hybrid
histopatholog
diagnosi
use
establish
diagnosi
endem
fungi
distinct
morpholog
howev
confus
may
occur
attempt
differenti
hyalin
mold
commonli
caus
invas
diseas
fusarium
spp
scedosporium
spp
distinguish
aspergillu
spp
tissu
section
even
zygomycet
morpholog
quit
distinct
fusarium
spp
presenc
mosaic
appear
groundglass
opac
may
repres
develop
bronchiol
obliteran
syndrom
oblit
bronchiol
absenc
biopsi
categor
probabl
presenc
histolog
find
acut
reject
fungal
invas
classifi
acut
reject
proven
fungal
infect
b
isol
nonpathogen
mold
cultur
eg
cladosporium
spp
phialemonium
chaetomium
cunninghamella
syncephalastrum
curvularia
dactylaria
graphium
phialophora
nonpathogen
fungi
eg
penicillium
nonmarnefii
paecilomyc
basidiomyct
qualifi
probabl
categori
consid
proven
categori
definit
fungal
pneumonia
tracheobronch
bronchial
anastomot
infect
colon
cttx
given
tabl
respect
noncttxspecif
infect
urinari
tract
infect
uti
surgic
site
infect
ssi
bloodstream
infect
bsi
infect
endocard
ie
clostridium
difficil
infect
cdi
skin
soft
tissu
infect
ssti
includ
herein
consensu
opinion
ishlt
id
council
encourag
use
previous
publish
intern
definit
infect
well
establish
outsid
cttx
popul
use
standard
definit
allow
intercent
comparison
rate
type
infect
significantli
impact
transplant
